204 related articles for article (PubMed ID: 28347837)
21. Meteorin reverses hypersensitivity in rat models of neuropathic pain.
Jørgensen JR; Xu XJ; Arnold HM; Munro G; Hao JX; Pepinsky B; Huang C; Gong BJ; Wiesenfeld-Hallin Z; Wahlberg LU; Johansen TE
Exp Neurol; 2012 Oct; 237(2):260-6. PubMed ID: 22766205
[TBL] [Abstract][Full Text] [Related]
22. An inhibitor of neuronal exocytosis (DD04107) displays long-lasting in vivo activity against chronic inflammatory and neuropathic pain.
Ponsati B; Carreño C; Curto-Reyes V; Valenzuela B; Duart MJ; Van den Nest W; Cauli O; Beltran B; Fernandez J; Borsini F; Caprioli A; Di Serio S; Veretchy M; Baamonde A; Menendez L; Barros F; de la Pena P; Borges R; Felipo V; Planells-Cases R; Ferrer-Montiel A
J Pharmacol Exp Ther; 2012 Jun; 341(3):634-45. PubMed ID: 22393248
[TBL] [Abstract][Full Text] [Related]
23. Suppressing SNAP-25 and reversing glial glutamate transporters relieves neuropathic pain in rats by ameliorating imbalanced neurotransmission.
Liu C; Guo QL; Huang CS; Zou WY; Song ZB
Chin Med J (Engl); 2013 Nov; 126(21):4100-4. PubMed ID: 24229681
[TBL] [Abstract][Full Text] [Related]
24. Neurotherapeutics to inhibit exocytosis from sensory neurons for the control of chronic pain.
Dolly JO; O'Connell MA
Curr Opin Pharmacol; 2012 Feb; 12(1):100-8. PubMed ID: 22188874
[TBL] [Abstract][Full Text] [Related]
25. Botulinum neurotoxin A and neurotoxin E cleavage products of synaptosome-associated protein of 25 kd exhibit distinct actions on pancreatic islet beta-cell Kv2.1 channel gating.
He Y; Elias CL; Huang YC; Gao X; Leung YM; Kang Y; Xie H; Chaddock JA; Tsushima RG; Gaisano HY
Pancreas; 2008 Jan; 36(1):10-7. PubMed ID: 18192874
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic effectiveness of botulinum neurotoxin A: potent blockade of autonomic transmission by targeted cleavage of only the pertinent SNAP-25.
Lawrence GW; Ovsepian SV; Wang J; Aoki KR; Dolly JO
Neuropharmacology; 2013 Jul; 70():287-95. PubMed ID: 23485402
[TBL] [Abstract][Full Text] [Related]
27. Bipartite Activation of Sensory Neurons by a TRPA1 Agonist Allyl Isothiocyanate Is Reflected by Complex Ca
Belinskaia M; Wang J; Kaza SK; Antoniazzi C; Zurawski T; Dolly JO; Lawrence GW
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674850
[TBL] [Abstract][Full Text] [Related]
28. Targeted delivery into motor nerve terminals of inhibitors for SNARE-cleaving proteases via liposomes coupled to an atoxic botulinum neurotoxin.
Edupuganti OP; Ovsepian SV; Wang J; Zurawski TH; Schmidt JJ; Smith L; Lawrence GW; Dolly JO
FEBS J; 2012 Jul; 279(14):2555-67. PubMed ID: 22607388
[TBL] [Abstract][Full Text] [Related]
29. Unilateral facial injection of Botulinum neurotoxin A attenuates bilateral trigeminal neuropathic pain and anxiety-like behaviors through inhibition of TLR2-mediated neuroinflammation in mice.
Chen WJ; Niu JQ; Chen YT; Deng WJ; Xu YY; Liu J; Luo WF; Liu T
J Headache Pain; 2021 May; 22(1):38. PubMed ID: 34000998
[TBL] [Abstract][Full Text] [Related]
30. Botulinum Neurotoxin Light Chains Expressed by Defective Herpes Simplex Virus Type-1 Vectors Cleave SNARE Proteins and Inhibit CGRP Release in Rat Sensory Neurons.
Joussain C; Le Coz O; Pichugin A; Marconi P; Lim F; Sicurella M; Salonia A; Montorsi F; Wandosell F; Foster K; Giuliano F; Epstein AL; Aranda Muñoz A
Toxins (Basel); 2019 Feb; 11(2):. PubMed ID: 30791373
[TBL] [Abstract][Full Text] [Related]
31. The impact of the migraine treatment onabotulinumtoxinA on inflammatory and pain responses: Insights from an animal model.
Reducha PV; Bömers JP; Edvinsson L; Haanes KA
Headache; 2024 Jun; 64(6):652-662. PubMed ID: 38700141
[TBL] [Abstract][Full Text] [Related]
32. Persistence of botulinum neurotoxin A demonstrated by sequential administration of serotypes A and E in rat EDL muscle.
Adler M; Keller JE; Sheridan RE; Deshpande SS
Toxicon; 2001; 39(2-3):233-43. PubMed ID: 10978741
[TBL] [Abstract][Full Text] [Related]
33. Bilateral analgesic effects of abobotulinumtoxinA (Dysport
Favre-Guilmard C; Chabrier PE; Kalinichev M
Eur J Pain; 2017 May; 21(5):927-937. PubMed ID: 28263010
[TBL] [Abstract][Full Text] [Related]
34. Botulinum Toxin for Neuropathic Pain: A Review of the Literature.
Oh HM; Chung ME
Toxins (Basel); 2015 Aug; 7(8):3127-54. PubMed ID: 26287242
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of neurotransmitter release by peptides that mimic the N-terminal domain of SNAP-25.
Apland JP; Adler M; Oyler GA
J Protein Chem; 2003 Feb; 22(2):147-53. PubMed ID: 12760419
[TBL] [Abstract][Full Text] [Related]
36. Botulinum Toxin for the Treatment of Neuropathic Pain.
Park J; Park HJ
Toxins (Basel); 2017 Aug; 9(9):. PubMed ID: 28837075
[TBL] [Abstract][Full Text] [Related]
37. Acute neuroprotection by the synaptic blocker botulinum neurotoxin E in a rat model of focal cerebral ischaemia.
Antonucci F; Cerri C; Maya Vetencourt JF; Caleo M
Neuroscience; 2010 Aug; 169(1):395-401. PubMed ID: 20447449
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the therapeutic usefulness of botulinum neurotoxin B, C1, E, and F compared with the long lasting type A. Basis for distinct durations of inhibition of exocytosis in central neurons.
Foran PG; Mohammed N; Lisk GO; Nagwaney S; Lawrence GW; Johnson E; Smith L; Aoki KR; Dolly JO
J Biol Chem; 2003 Jan; 278(2):1363-71. PubMed ID: 12381720
[TBL] [Abstract][Full Text] [Related]
39. Importance of two adjacent C-terminal sequences of SNAP-25 in exocytosis from intact and permeabilized chromaffin cells revealed by inhibition with botulinum neurotoxins A and E.
Lawrence GW; Foran P; Mohammed N; DasGupta BR; Dolly JO
Biochemistry; 1997 Mar; 36(11):3061-7. PubMed ID: 9115981
[TBL] [Abstract][Full Text] [Related]
40. The analgesic effect on neuropathic pain of retrogradely transported botulinum neurotoxin A involves Schwann cells and astrocytes.
Marinelli S; Vacca V; Ricordy R; Uggenti C; Tata AM; Luvisetto S; Pavone F
PLoS One; 2012; 7(10):e47977. PubMed ID: 23110146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
